|
Global Immunology Partnering 2012-2018: Deal trends, players and financials |
Sep 1 2018 |
1000 |
Global |
$2,995.00 |
|
|
Global Surgery Partnering 2012 to 2018 |
Sep 1 2018 |
200 |
Global |
$1,995.00 |
|
|
Global Breast Cancer Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Muscular Dystrophy Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Motor Neurone Disease Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Bipolar Disorder Partnering 2012-2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics 2012-2018 |
Sep 1 2018 |
1000 |
Global |
$2,995.00 |
|
|
Global Crohn's Disease Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Tropical Disease Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Cancer Symptoms Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Contraception Partnering 2012-2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Hematology Partnering 2012-2018: Deal trends, players and financials |
Sep 1 2018 |
600 |
Global |
$2,995.00 |
|
|
Global Blood Substitutes Partnering 2012-2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Bladder Cancer Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Rheumatoid Arthritis Partnering 2012 to 2018 |
Sep 1 2018 |
200 |
Global |
$1,995.00 |
|
|
Global Spinal Cord Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Dementia Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Academic and Non-Profit Partnering Terms and Agreements 2012-2018: Deal trends, players and financials |
Sep 1 2018 |
1000 |
Global |
$2,995.00 |
|
|
Global Wound Healing Partnering 2012 to 2018 |
Sep 1 2018 |
250 |
Global |
$1,995.00 |
|
|
Global Parasitic Disease Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Prostate Cancer Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
The Mid-Size Pharmaceutical Market: Market Assessment, Growth Forecasts and Strategic Consolidations for Key Players |
May 4 2018 |
140 |
Global |
$2,995.00 |
|
|
Acne Vulgaris - Epidemiology Forecast to 2026 |
Mar 1 2018 |
37 |
Global |
$3,995.00 |
|
|
OpportunityAnalyzer: Late - Stage Chronic Kidney Disease - Opportunity Analysis and Forecasts to 2026 |
Dec 31 2017 |
195 |
Global |
$10,995.00 |
|
|
PharmaPoint: Glaucoma - Global Drug Forecast and Market Analysis to 2026 |
Dec 20 2017 |
280 |
Global |
$10,995.00 |
|
|
PharmaPoint: Irritable Bowel Syndrome (IBS) - Global Drug Forecast and Market Analysis to 2026 |
Dec 20 2017 |
185 |
Global |
$10,995.00 |
|
|
Global Epilepsy Partnering 2010 to 2017 |
Sep 1 2017 |
150 |
Global |
$1,495.00 |
|
|
Global Respiratory Partnering 2010-2017: Deal trends, players and financials |
Sep 1 2017 |
800 |
Global |
$2,995.00 |
|
|
Global Drug Addiction Partnering 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Roche Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
